BioStem Technologies, Inc.
BSEM
$14.69
$0.1621.12%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 520.51% | 285.62% | 224.08% | 26.34% | -102.32% |
| Total Depreciation and Amortization | 77.32% | -16.28% | -6.61% | -5.54% | -9.53% |
| Total Amortization of Deferred Charges | 200.79% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -269.49% | 151.04% | 31.03% | -36.97% | 1,971.36% |
| Change in Net Operating Assets | 1,764.05% | -1,987.81% | -2,139.04% | -343.18% | -183.75% |
| Cash from Operations | 2,519.47% | 717.30% | 183.99% | -218.77% | -23.31% |
| Capital Expenditure | -27.52% | -414.34% | 79.30% | 100.00% | -533.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 53.52% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -47.39% | 100.00% |
| Cash from Investing | -1,325.55% | -413.11% | 92.49% | 100.00% | -53.34% |
| Total Debt Issued | -- | -- | -- | -91.88% | -- |
| Total Debt Repaid | 49.75% | -115.30% | -8,236.17% | 10.08% | -31,633.33% |
| Issuance of Common Stock | 41.84% | -100.00% | 19.05% | -- | 41.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -115.91% | -118.56% | -168.80% | 531.99% | 456.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,859.42% | 3,286.01% | 164.76% | 148.09% | 35.32% |